Schmidt, Carsten https://orcid.org/0000-0002-3022-2021
Bokemeyer, Bernd
Lügering, Andreas
Bettenworth, Dominik
Teich, Niels
Fischer, Imma
Hammer, Leonie
Kolterer, Stefanie
Rath, Stefan
Stallmach, Andreas
,
Funding for this research was provided by:
Universitätsklinikum Jena
Article History
Accepted: 16 January 2022
First Online: 27 January 2022
Declarations
:
: The protocol of this study was in accordance with ethical standards as laid down by the ethics committee of the Jena University Hospital (4102–06/14). The study was performed in accordance with the principles of the Declaration of Helsinki and its later amendments.
: Freely given, informed consent was obtained in written form from all individual participants before their inclusion in the study.
: C Schmidt obtained consulting fees from AbbVie, Amgen, Biogen, Ewopharma, Galapagos, Janssen, MSD, Pfizer, and Takeda; lecture fees and travel support from AbbVie, Berlin Chemie, Biogen, CED Service, Ewopharma, Falk, Janssen, Med Update, Merckle, MSD Sharp & Dohme, Norgine, Novartis, Olympus, Pentax, Pfizer, Shire, Shield Therapeutics, and Takeda; and research support from AbbVie, Olympus, and Pentax. B Bokemeyer has received consulting fees from AbbVie, MSD, Shire, Ferring, UCB, Hospira, Takeda, Movetis, Shield Therapeutics, Pfizer, Biogen, Janssen, Hexal, Cellgene, Boehringer, Allergan, Galapagos, and Celltrion; has provided speaking and teaching services for AbbVie, Ferring, MSD, Merckle, Falk, HLR, UCB, Shield Therapeutics, Pfizer, Celltrion, Takeda, Janssen, Mundipharma, and Tillotts; and has received grants and research funding form AbbVie, Ferring, UCB, Given Imaging, Janssen, Takeda, Pfizer, and Galapagos. D Bettenworth is on the advisory board or a consultant for AbbVie, Amgen, Arena, Bristol Myers Squibb, Celltrion, Else Kröner-Fresenius-Stiftung, Dr. Falk Foundation, Ferring, Galapagos, Guidepoint, MSD, Medical Tribune, Pfizer, Pharmacosmos, Roche, Takeda, Thieme, Tillotts Pharma, Viatris, and Vifor. I Fischer has received consulting fees from AbbVie. N Teich reports personal fees from AbbVie, Celltrion, Falk Foundation, Janssen, MSD, Takeda, and Pfizer outside the submitted work. A Stallmach reports research funding from AbbVie and Celltrion and has received lecture fees from AbbVie, Amgen, Astellas, Biogen, Celltrion, Institut Allergosan, Janssen, Falk Foundation, Ferring, MSD, RecordatiPharma, Streamed-Up, and Takeda and consulting fees from AbbVie, Astellas, Amgen, Biogen, CLS Behring, Consal, Galapagos, Hexal, Janssen, MSD, Norgine, Pfizer Pharma, Takeda, and Tillotts Pharma. A Lügering has received advisory board or consulting fees from AbbVie, Ferring, Janssen, MSD, Pfizer, Takeda, and Tillotts Pharma. L Hammer, S Kolterer, and S Rath are AbbVie employees and may own AbbVie stock or options.